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Abstract: A 32-year prospective observational study was initiated in 1968, including 1462 
women aged 60, 54, 50, 46, and 38, representative of the female population in these age groups. 
Measures included self-reported nervous symptoms and moodiness at baseline, menopausal 
status, risk factors as smoking, s-cholesterol, s-triglycerides, body mass index (BMI), waist–hip 
ratio (WHR), blood pressure, and socioeconomic status (SES). The prevalence of nervousness 
and moodiness was investigated as well as if these reported symptoms could predict mortality 
and morbidity within 32 years in pre-and postmenopausal women. Women who reported at 
least two of the symptoms suffered from an increased risk of 32-year mortality, independent of 
all background variables described above (hazard ratio [HR] = 1.28, conﬁ  dence interval [CI] 
1.03–1.58). Women with only one of the nervous symptoms already had an increased risk of 
suffering from cardiovascular disease (CVD) also after multivariable adjustment (HR = 1.29, 
CI 1.09–1.52) a risk that also remained signiﬁ  cant when analyzing CVD risk in the group of 
premenopausal women (HR = 1.28, CI 1.02–1.62). There was no signiﬁ  cantly increased risk 
among pre-or postmenopausal women with perceived nervousness/moodiness of developing 
cancer during the 32-year follow-up. There seems to be an association between nervousness/
moodiness and premature mortality and morbidity in CVD, especially when present already in 
the premenopausal state in women.
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Introduction
As early as in 1950, Terman and his colleagues reported that degree of psychological 
maladjustment, cumulatively rated, was related to higher risk of all-cause mortality 
over a four-decade follow-up period.1 The differences among causes of death were 
nonsigniﬁ  cant, but there was some indication that mental health problems were more 
strongly related to deaths from injury and cardiovascular disease (CVD). The overall 
relationship was signiﬁ  cant for men but weaker for women.1
A recently published Swedish study, based on data from national surveys and 
registers, showed that perceived nervousness, uneasiness, and anxiety were strongly 
related to subsequent risks of suicide attempt and psychiatric disease as well as all-cause 
mortality, hospital care, and ischemic heart disease in both men and women.2
Several earlier studies in primary care have shown that depressed patients have 
impaired health-related quality of life (HRQoL) and that these patients score lower 
in this respect than patients with common chronic physical disorders.3 In some 
instances, speciﬁ  c psychoaffective patterns could be associated with particular International Journal of General Medicine 2009:2 40
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physical diseases. For example depression has been linked to 
increased morbidity and mortality due to cardiac events4,5 and 
myocardial infarction6,7 whereas mixed anxiety–depression 
did not relate to excess mortality.8 However, there is an 
association between extreme anxiety and sudden cardiac 
death, where panic-like anxiety is an independent risk factor,9 
as well as with increased mortality.7
Some studies have reported that depression increased 
the risk of death in elderly men but not in women,8,10,11 
pointing to a gender difference in this association. It has 
long been recognized that women are at a higher risk than 
men to develop depression and that such risk is particularly 
associated with reproductive cycle events.12
There are not many studies concerning associations 
between nervousness/moodiness and cancer. Most studies 
report from patients who already have a cancer diagnosis 
and then relate the cancer diagnose to nervousness or mental 
stress. A Swedish study hypothesized that stressful psycho-
social working conditions would be involved in the etiology 
of esophageal and gastric cardia cancers in men, but was 
unable to prove the hypothesis.13
The purpose of this study was to investigate if perceived 
nervousness and moodiness can predict mortality and mor-
bidity within 32 years in women, and if so, independently 
of other well known risk factors as age, smoking, hyperten-
sion, s-cholesterol, s-triglycerides, body mass index (BMI), 
waist–hip ratio (WHR), socioeconomic status (SES), and 
education14,15 and also to relate possible associations to meno-
pausal status. We used data from the Prospective Population 
Study of Women in Gothenburg.
Participants and methods
Study population
In 1968–1969, 1462 women aged 60, 54, 50, 46, and 38 
in Gothenburg, Sweden, participated in the Prospective 
Population Study of Women in Gothenburg. The sampling 
was based on date of birth which together with the high par-
ticipation rate (90.1%), ensured that the participants were a 
representative cross-section of women from the community in 
the age groups studied.16 All women examined in 1968–1969 
were offered examinations in 1974–1975, in 1980–1981, 
and in 1992–1993. In 2000–2001, the ﬁ  fth examination, a 
32-year follow-up study, with a participation rate of 70% 
among those still alive, took place. Details of the sampling 
procedure and participation rates at all examinations were 
presented elsewhere.16–20 We studied mortality and severe 
morbidity over 32 years and we used data from the National 
Cause of Death Register and the Swedish Hospital Patient 
Register. The Swedish Hospital Patient Register contains 
data about all discharges from Swedish hospitals (overnight 
patients 1980–2001).
Deﬁ  nition of nervousness and moodiness
The presence of nervousness and moodiness was based on 
a self-administered questionnaire where nervousness was 
deﬁ  ned as answers yes to the question a) “Have you had any 
of the following illnesses/symptoms: psychological/nervous 
symptoms?” The women who reported having psychological/
nervous symptoms were deﬁ  ned as having nervousness.
The prevalence of moodiness was based on answers 
yes to one or both of the questions b1) “Do you usually 
feel downhearted and/or discouraged; at the moment/in 
the mornings/during the days/in the evenings?” or b2) 
“Regarding the problems of everyday life: Do you usually 
feel anxious and worried about them in advance?” All women 
reporting nervous symptoms and/or moodiness according to 
the above indicated questions were deﬁ  ned as belonging to 
the group with nervousness/moodiness (NM). Two different 
variables were used: i) NM1, corresponding to answering 
yes to at least one of the questions about the symptoms 
nervousness/ moodiness (a or b) (eg, “Yes, I feel downhearted 
in the mornings), and ii) NM2, corresponding to answering 
yes to at least two symptoms nervousness/moodiness (a and 
b) (eg, “Yes, I feel downhearted in the mornings” as well as 
“Yes, I have psychological/nervous symptoms”).
Deﬁ  nition of CVD and hypertension
A woman was deﬁ  ned as having CVD if the diagnosis had 
been made by a doctor and was classiﬁ  ed according to the 
International Classiﬁ  cation of Diseases, Ninth and Tenth 
Revision (ICD 9 and 10), diagnosis codes ICD 391-448B 
or I01.0–I79.2, respectively (myocardial infarction, heart 
failure, other cardiovascular diseases, stroke). Risk time 
for CVD was calculated from the day the woman was 
admitted to hospital with this diagnosis (reliable data from 
Swedish Hospital Register was attained from 1980–2001). 
Women who reported having CVD (myocardial infarction 
or stroke) at start of the examinations in 1968–1969 were 
excluded. Hypertension/high blood pressure was deﬁ  ned as 
using antihypertensive medication and/or a systolic pressure 
160 mmHg and/or diastolic blood pressure 95 mmHg at 
the time of the examination.
Veriﬁ  cation of cancer diagnosis
We used data from the Swedish Cancer Registry and from 
regional cancer registries. Each participant was also asked if International Journal of General Medicine 2009:2 41
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she had any history of neoplastic disease and, if so, she was 
asked to provide details on type, localization and treatment. 
Information from the total 32-year period 1968–1969 to 
2000–2001 was obtained. Risk time for cancer was calculated 
to the month the woman got the diagnosis. A comparison 
between the 1988 Cancer Registry and the observations made 
in the Prospective Population Study of Women has shown 
that all but one out of 103 cases (99%) were registered in 
the Cancer Registry and all but one (99%) in the Prospec-
tive Population Study of Women.18 Women who reported 
having cancer at start of the examinations in 1968–1969 
were excluded.
Deﬁ  nition of menopausal status
Menstrual status was obtained from a questionnaire and 
checked by interview by a physician. Information obtained in 
1968–1969 was also veriﬁ  ed retrospectively in 1974–1975. 
Menopause was deﬁ  ned as more than 12 months without 
menstruation.21
Measured CVD risk factors at baseline
Physical examinations were conducted according to the same 
protocol at all examinations with respect to body weight, 
body height, BMI, waist circumference, hip circumference, 
WHR, systolic and diastolic blood pressure measurements 
(sitting position after ﬁ  ve minutes’ rest).16 Blood samples 
were drawn after an overnight fast. Serum levels of total 
cholesterol, s-triglycerides, and b-glucose were analyzed 
according to standard methods of the laboratory of the Sahl-
grenska University Hospital, Gothenburg. These variables 
were entered as continuous covariates in the multivariate 
models.
Social and lifestyle-related variables 
at baseline
Women were classiﬁ  ed as smokers (women who smoked or 
had stopped smoking during the previous year), ex-smokers 
(women who had stopped smoking more than a year before 
examination) and nonsmokers (women who never smoked). 
Women reported their own occupation and income and, if 
they were married, their husbands’ occupation and income. 
This information was transformed according to Carlsson’s 
standard occupations grouping system.22 We combined 
group one (large-scale employers and ofﬁ  cials of high or 
intermediate rank) and groups two and three (small-scale 
employers, lower-rank ofﬁ  cials, and supervisors) into “high 
and medium social class group.” Groups four and five 
(skilled and unskilled workers) were classiﬁ  ed as a “lower 
social class group.” Women with only “basic” education 
(ca. six years, depending on cohort) were classiﬁ  ed as less 
educated. Women reported about number of children.23 
These variables were entered as categorical variables in the 
multivariate models.
Statistical methods
Fisher’s exact test was used to test the hypothesis of no dif-
ferences in prevalence of symptoms between the two groups 
(women with/without nervousness and /or moodiness in 
1968–1969). Associations between mortality and morbid-
ity and NM1 and NM2, respectively, were tested in Cox 
regression proportional hazards models with nervousness/
moodiness, smoking, s-cholesterol, s-triglycerides, BMI, 
WHR, hypertension, social group, education and number of 
children as independent variables. Since BMI as a risk factor 
is supposed to be J-shaped and presumed to have an irregular 
effect of the outcome variables, we included both a linear 
and quadratic effect of BMI in the regression models. The 
proportional hazards assumptions was tested and veriﬁ  ed.
Ethical approval and participants consent
The Ethics Committee of University of Gothenburg approved 
the study. All subjects in the 2000–2001 examinations gave 
informed consent, in accordance with the provisions of the 
Helsinki Declaration.
Results
Basal data on nervous symptoms 
and their association with mortality 
during a 32-year follow-up period
Table 1 describes prevalence of nervousness and moodiness 
among the women in 1968–69, divided into different birth 
cohorts, as well as 32-year mortality. Around 60% (862 par-
ticipants) of the women reported not suffering from nervous-
ness/moodiness with no signiﬁ  cant differences between the 
different age cohorts (p = 0.9) (data not shown). Within the 
32 years, 524 women died. Table 1 also describes CVD and 
cancer morbidity in the different age groups 1968–2001.
Women who reported at least one of the symptoms 
nervousness and/or moodiness suffered from an increased 
mortality (39% vs 33%) during the 32-year follow-up period 
(Table 1). The association between two of the symptoms, 
nervousness and/or moodiness and mortality, was tested in 
a Cox proportional hazards model, showing a signiﬁ  cantly 
increased risk when controlled for age, as well as after 
adjustment for all other baseline data (smoking, hypertension, International Journal of General Medicine 2009:2 42
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s-cholesterol, s-triglycerides, BMI, WHR, SES, education, 
number of children) (Table 2).
Basal data on nervous symptoms 
and their association to incidence 
of CVD and cancer during a 32-year 
follow-up period
Cardiovascular disease
There were totally 205 women who suffered from CVD, 
which had rendered stay overnight at hospital during 1980 
until 2001 (Table 1). Women who had reported one of the 
symptoms of nervousness/moodiness in 1968–1969 had a 
signiﬁ  cantly higher risk of CVD within 32 years, even after 
controlling for other risk factors (Table 3). Women who had 
reported at least two symptoms of nervousness/moodiness 
in 1968–1969 also had a signiﬁ  cantly higher risk of CVD 
within 32 years, both when controlling for age, and with 
multivariable control (Table 3).
When studying the increased risk with regard to 
menopausal status in 1968–1969 women in the premenopausal 
group, with reported nervousness and/or moodiness, showed 
signiﬁ  cantly increased risk of CVD also after multivariable 
adjustment (Table 3). Concerning the postmenopausal 
group, women who reported at least one of the symptoms 
nervousness/moodiness showed signiﬁ  cantly increased risk 
of CVD when controlling for age, but not multivariable 
controlled (Table 3).
Most important risk factors in the models were WHR, 
smoking and s-triglycerides; for the premenopausal group: 
WHR and smoking, and for the postmenopausal group: 
WHR, smoking and triglycerides. Introducing one risk factor 
at a time revealed no factor more prominent than the other. 
Belonging to a high social group was a protective factor.
Cancer
There were 361 women who suffered from cancer 
within 32 years (Table 1). Women with reported 
nervousness/moodiness did not suffer from cancer in a 
higher degree than women without these symptoms in 
1968–1969 (Tables 2 and 3).
Discussion
In the present study, women with perceived nervousness/
moodiness in 1968–1969 showed a signiﬁ  cantly increased 
risk of mortality over 32 years. A statistically increased 
risk of suffering from CVD remained in premenopausal 
women, with perceived nervousness/moodiness, even 
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other hand, an increased risk of stroke among younger 
women (30–60 years) has been observed in Sweden during 
the last decades.25 This could indicate that younger, premen-
strual women in our society have a higher susceptibility to 
eg, mental stress. The inﬂ  uence of ovarian hormones on the 
stress and immune responses during the reproductive stages 
in women’s lives is still not fully understood.26 There seems 
to be no simple explanation.
Table 2 Association between nervousness/moodiness (NM1 
and NM2) and risk of death in a 32-year perspective; all women 
divided into two groups, controlled for age and all risk factors, 
respectively.   Total mortality, CVD mortality, and cancer mortality 
are presented
nH R C I p
Total mortality
 NM1  + age 1347 1.18 0.98–1.42 0.07
 Multivariable 1347 1.12 0.94–1.35 0.21
 NM2  + age 1347 1.39 1.13–1.72 0.002
 Multivariable 1347 1.28 1.03–1.58 0.02
CVD mortality
 NM1  + age 1347 1.38 1.04–1.83 0.03
 Multivariable 1347 1.33 1.00–1.77 0.05
 NM2  + age 1347 1.58 1.14–2.18 0.005
 Multivariable 1347 1.47 1.06–2.04 0.02
Cancer mortality
 NM1  + age 1347 0.86 0.61–1.20 0.37
 Multivariable 1347 0.82 0.58–1.14 0.24
 NM2  + age 1347 0.90 0.59–1.38 0.63
 Multivariable 1347 0.83 0.54–1.27 0.39
Abbreviations: CVD, cardiovascular disease; HR, hazards ratio; CI, conﬁ  dence 
interval.
after controlling for well known risk factors, including 
socioeconomic status and lifestyle factors. Women 
who reported perception of least two symptoms of 
nervousness/moodiness showed increased risk of both total 
and CVD mortality, as well as earlier found association 
with increased CVD morbidity in the group of women 
premenopausal in 1968–1969.
A previous study of Swedish men and women showed 
an association between nervousness and anxiety and 10-year 
mortality. Speciﬁ  cally there were much stronger associations 
among men and with no signiﬁ  cant association concerning 
ischemic heart disease in women and much weaker associa-
tions concerning female mortality and morbidity over all.2 In 
our longitudinal study, the women, representative of the 
population, were thoroughly examined at baseline, which 
made it possible to control for several known risk factors, 
both concerning socioeconomic status and education as well 
as lifestyle variables.
Perceived nervousness and moodiness seems to be 
associated with increased risk of suffering from CVD, 
especially in premenopausal women. This in a way 
contradicts many studies which have shown that estro-
gen deﬁ  ciency after spontaneous or medically induced 
menopause is an important risk factor for CVD.24 On the 
Table 3 Association between nervousness/moodiness (NM1 and 
NM2) and CVD and cancer morbidity, respectively, in a 32-year 
perspective; all women presented as well as divided in groups for 
premenopausal and postmenopausal in 1968–1969. Calculations 
controlled for age as well as multivariable controlled presented
CVD morbidity n HR CI p
All women
 NM1  + age 1344 1.32 1.12–1.56 0.001
 Multivariable 1344 1.29 1.09–1.52 0.003
 NM2+ age 1344 1.32 1.08–1.60 0.006
 Multivariable 1344 1.27 1.04–1.54 0.02
Women premenopausal 
in 1968–1969
 NM1+ age 828 1.28 1.02–1.61 0.03
 Multivariable 828 1.28 1.02–1.62 0.03
 NM2  + age 828 1.46 1.10–1.93 0.009
 Multivariable 828 1.44 1.08–1.91 0.01
Women postmenopausal 
in 1968–1969
 NM1  + age 449 1.32 1.03–1.70 0.03
 Multivariable 449 1.21 0.94–1.56 0.13
 NM2  + age 449 1.10 0.83–1.47 0.49
 Multivariable 449 1.02 0.76–1.36 0.89
Cancer morbidity
 NM1  + age 1345 1.02 0.82–1.28 0.86
 Multivariable 1345 1.00 0.80–1.25 0.98
 NM2  + age 1345 1.09 0.83–1.42 0.55
 Multivariable 1345 1.05 0.80–1.38 0.72
Women premenopausal 
in 1968–1969
 NM1  + age 828 1.18 0.87–1.58 0.28
 Multivariable 828 1.14 0.84–1.53 0.40
 NM2  + age 828 1.13 0.78–1.66 0.50
 Multivariable 828 1.08 0.74–1.57 0.69
Women postmenopausal 
in 1968–1969
 NM1  + age 450 0.90 0.62–1.30 0.57
 Multivariable 450 0.92 0.63–1.34 0.65
 NM2  + age 450 1.02 0.66–1.58 0.93
 Multivariable 450 1.03 0.67–1.60 0.89
Abbreviations: HR, hazards ratio; CI, conﬁ  dence interval.International Journal of General Medicine 2009:2 44
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Estrogen has been used in the treatment of adult-onset 
depressive and anxiety symptoms in postmenopausal women, 
most often with little or no effect on symptoms.27 Hormone 
replacement therapy (HRT) use in 1968 in 50-year-old 
women was very low; 2% of 50-year-old women and 5% of 
54-year-old women used HRT during more than a month in 
the 1968–1969 year examination.21 This makes any inﬂ  uence 
of importance on presented results unlikely.
Most associations found between nervousness/moodi-
ness and mortality as well as morbidity could be explained 
in several ways, eg, by association of the symptoms with 
other health related conditions. Smoking is more prevalent 
in persons with psychological/mental distress.28 Depres-
sive symptoms and stressful life events have been found to 
be associated with the metabolic syndrome, eg abdominal 
adiposity and high s-triglycerides, in the Healthy Women’s 
Study.29 The association between morbidity and mortality 
indicators and low socioeconomic status has been observed 
for many centuries and previously reported in this cohort.30 
Certain studies have shown that lower social class is 
associated with a high frequency and severity of perceived 
distress.31,32 As always, cause or effect cannot be revealed by 
observational studies, not even population based prospective 
studies, and we can only speculate if the association between 
perceived nervousness/moodiness and CVD morbidity is a 
direct or indirect effect via increased risk contributable to eg, 
smoking, psychosocial stress, or poor lifestyle.
The advantages of this study is the longitudinal design 
and the high participation rate following the women in the 
original study in 1968–1969 until the follow-up study in 
2000–2001, using exactly the same examination protocol in 
all follow-ups.
There are some limitations to this study. We used the 
women’s own perception of nervousness/moodiness rather 
than a more sophisticated medical instrument or doctors’ 
diagnoses. The psychological symptoms were subjectively 
and individually reported. On the other hand, a symptom is 
a symptom and not a diagnosis or an illness and it is only the 
person herself who can state if she perceives the symptom 
or not. The corresponding way of documenting nervousness 
was also used in the reported Swedish study.2 Prevalence of at 
least one symptom of nervousness or moodiness was higher 
in our study compared to that study, but corresponding ﬁ  gures 
were reached when using the variable at least two symptoms 
nervousness/moodiness.
In conclusion, this study shows that there seems to exist an 
association between nervousness/moodiness and morbidity, 
especially concerning CVD morbidity in premenopausal 
women, but the associations could to some extent be explained 
by background variables. This could be another example of the 
close association between socioeconomic and psychosocial 
factors, where cause or effect cannot be determined.
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